위암 환자에서 복강경 보조하 위절제술 179례에 대한 분석

Abstract

Laparoscopic gastrectomy is gaining wider acceptance for the treatment of early gastric cancer. The purpose of this study was to determine the feasibility and safety of laparoscopy-assisted gastrectomy with lymph node dissection for gastric cancer. We retrospectively evaluated the clinicopathologic characteristics and operative outcome of 179 patients with gastric cancer treated with laparoscopy-assisted gastrectomy performed consecutively by one surgeon. Of the 179 patients, distal gastrectomy was performed in 172 patients (96.1%) and total gastrectomy in 7 patients (3.9%). And 155 patients (86.6%) had early gastric cancer and 24 patients (13.4%) had advanced gastric cancer. The mean operation time was 252.28 ± 62.13 minutes and mean blood loss was 72.22 ± 71.80 ml. The mean number of retrieved lymph nodes was 50.68 ± 19.40. The mean time to sips of water and postoperative hospital stay were 2.72 ± 0.92 and 8.73 ± 5.64 days, retrospectively. Complications occurred 24 patients (13.4%). Open conversion occurred 1 patient (0.56%) and hospital death occurred 1 patient (0.56%). Laparoscopy-assisted gastrectomy with lymph node dissection is a technically feasible and safe operation for gastric cancer. Laparoscopy-assisted gastrectomy can be a curative and minimally invasive treatment for gastric cancer.